C
Conduit Pharmaceuticals Inc
NASDAQ:CDT
Conduit Pharmaceuticals Inc
NASDAQ:CDT
Price:
4.22
USD
6.84%
Market Closed
Market Cap:
$18.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
Conduit Pharmaceuticals Inc
NASDAQ:CDT
|
US |
|
M
|
MHC JSC
VN:MHC
|
VN |
|
Lasertec Corp
TSE:6920
|
JP |
|
A
|
AECC Aviation Power Co Ltd
SSE:600893
|
CN |
|
Home24 SE
XETRA:H24
|
DE |
|
Shenyang Huitian Thermal Power Co Ltd
SZSE:000692
|
CN |
|
T
|
Tat Gida Sanayi AS
IST:TATGD.E
|
TR |
|
Jinxin Fertility Group Ltd
HKEX:1951
|
CN |
|
SYN prop e tech SA
BOVESPA:SYNE3
|
BR |
|
G
|
Ganges Securities Ltd
NSE:GANGESSECU
|
IN |
|
Eole Inc
TSE:2334
|
JP |
|
Zhejiang Jinke Tom Culture Industry Co Ltd
SZSE:300459
|
CN |
|
Q
|
QTC Energy PCL
SET:QTC
|
TH |
|
X5 Retail Group NV
LSE:FIVE
|
RU |
|
Lloyds Enterprises Ltd
NSE:LLOYDSENT
|
IN |
Cash Flow Statement
Cash Flow Statement
Conduit Pharmaceuticals Inc
Conduit Pharmaceuticals Inc
Currency: USD
| Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||
| Net Income |
(5)
|
(6)
|
(9)
|
(5)
|
(1)
|
(2)
|
(5)
|
(14)
|
(18)
|
(19)
|
(20)
|
(20)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
|
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
1
|
1
|
2
|
|
| Other Non-Cash Items |
2
|
2
|
3
|
(1)
|
(5)
|
(4)
|
(1)
|
5
|
8
|
8
|
7
|
6
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
1
|
0
|
2
|
2
|
(3)
|
(2)
|
(3)
|
(2)
|
(0)
|
(1)
|
(1)
|
(3)
|
|
| Cash from Operating Activities |
(2)
N/A
|
(3)
-52%
|
(4)
-8%
|
(4)
-2%
|
(8)
-103%
|
(8)
-5%
|
(9)
-13%
|
(11)
-16%
|
(10)
+9%
|
(12)
-20%
|
(12)
-6%
|
(15)
-20%
|
|
| Investing Cash Flow | |||||||||||||
| Capital Expenditures |
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
|
| Other Items |
(0)
|
(0)
|
(1)
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
(0)
N/A
|
(0)
-133%
|
(1)
-21%
|
0
N/A
|
1
+317%
|
1
+34%
|
1
-14%
|
0
-56%
|
(0)
N/A
|
(0)
-9%
|
(0)
-377%
|
(1)
-488%
|
|
| Financing Cash Flow | |||||||||||||
| Net Issuance of Common Stock |
1
|
0
|
1
|
1
|
0
|
0
|
0
|
2
|
4
|
12
|
15
|
20
|
|
| Net Issuance of Debt |
1
|
3
|
3
|
3
|
2
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
|
| Other |
0
|
0
|
0
|
9
|
9
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
2
N/A
|
4
+58%
|
4
+8%
|
12
+192%
|
11
-11%
|
9
-20%
|
8
-4%
|
1
-83%
|
6
+320%
|
12
+98%
|
16
+30%
|
20
+27%
|
|
| Change in Cash | |||||||||||||
| Effect of Foreign Exchange Rates |
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
(0)
|
|
| Net Change in Cash |
0
N/A
|
0
N/A
|
(0)
N/A
|
9
N/A
|
4
-51%
|
2
-57%
|
0
-88%
|
(9)
N/A
|
(4)
+57%
|
0
N/A
|
3
+988%
|
4
+21%
|
|
| Free Cash Flow | |||||||||||||
| Free Cash Flow |
(2)
N/A
|
(3)
-52%
|
(4)
-8%
|
(4)
-2%
|
(8)
-103%
|
(8)
-5%
|
(9)
-13%
|
(11)
-16%
|
(10)
+9%
|
(12)
-20%
|
(13)
-9%
|
(16)
-26%
|
|
Switch to:
Switch to:
See Also
Discover More
